Deerfield Management Company
Latest statistics and disclosures from Deerfield Management Company's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Horizon Therapeutics Plc, Horizon Pharma Plc convertible security, Mylan Nv, Nevro Corp note 1.750% 6/0, Orchard Therapeutics Plc ads, and represent 29.44% of Deerfield Management Company's stock portfolio.
- Added to shares of these 10 stocks: Rhythm Pharmaceuticals Inc (+$42.43M), Mirum Pharmaceuticals Inc (+$34.70M), Aerie Pharmaceuticals (+$29.52M), Clovis Oncology Inc note 2.500% 9/1 (+$26.72M), Springworks Therapeutics Inc (+$22.78M), CNC (+$18.06M), Tandem Diabetes Care Inc (+$17.80M), Silk Road Medical Inc Common (+$15.63M), Axogen (+$11.87M), Inogen (+$9.18M).
- Started 16 new stock positions in ABMD, Castle Biosciences Inc, ATRC, Viewray, Mirum Pharmaceuticals Inc, Provention Bio Inc, Springworks Therapeutics Inc, Avrobio Ord, Kempharm, Forty Seven Inc. Agile Therapeutics, Inogen, Aimmune Therapeutics, Guardant Health Inc, Alphatec Holdings, Igm Biosciences Inc Com.
- Reduced shares in these 10 stocks: Insulet Corp note 1.375%11/1 (-$52.04M), Dexcom Inc dbcv 0.750% 5/1 (-$32.00M), Natera (-$27.66M), Exact Sciences Corp convertible/ (-$25.80M), STAA (-$25.75M), Nevro (-$25.02M), IMMU (-$23.49M), Invitae (-$23.39M), Diplomat Pharmacy (-$19.80M), Shockwave Med Inc (-$17.82M).
- Sold out of its positions in Aclaris Therapeutics, Adaptive Biotechnologies Cor, Anthem, Athenex, Chewy Inc cl a, Dexcom Inc dbcv 0.750% 5/1, Exact Sciences Corp convertible/, Inspire Med Sys Inc, Insulet Corp note 1.375%11/1, Invitae. Natera, Nevro, Orthopediatrics Corp., Pfenex, Phasebio Pharmaceuticals Inc, Shockwave Med Inc, Sorrento Therapeutics, STAA.
- Deerfield Management Company was a net seller of stock by $90.42M.
- Deerfield Management Company has $2.45B in assets under management (AUM), dropping by -11.92%.
Companies in the Deerfield Management Company portfolio as of September 2019 quarter
| Company (Ticker) | Portfolio Weight | Share Count | Change in Shares | Price |
|---|---|---|---|---|
| Horizon Therapeutics Plc | 7.18 | 6.46M | 27.23 | |
| Horizon Pharma Plc convertible security | 6.43 | 136.03M | 1.16 | |
| Mylan Nv | 6.17 | 7.65M | +2% | 19.78 |
| Nevro Corp note 1.750% 6/0 | 5.33 | 115.78M | 1.13 | |
| Orchard Therapeutics Plc ads | 4.32 | 8.92M | 11.88 | |
| Homology Medicines Inc | 4.25 | 5.76M | 18.10 | |
| Aerie Pharmaceuticals | 3.58 | 4.57M | +50% | 19.22 |
| Rhythm Pharmaceuticals Inc | 2.28 | 2.59M | +314% | 21.59 |
| Brookdale Senior Living (BKD) | 2.23 | 7.21M | 7.58 | |
| Intersect Ent | 2.16 | 3.11M | 17.01 | |
| Acceleron Pharma | 2.10 | 1.31M | 39.51 | |
| Myokardia | 2.09 | 981430 | 52.15 | |
| Intercept Pharmas conv | 2.03 | 57.79M | 0.86 | |
| Immunomedics (IMMU) | 1.74 | 3.21M | -35% | 13.26 |
| Clovis Oncology Inc note 2.500% 9/1 | 1.72 | 49.06M | +172% | 0.86 |
| Ra Pharmaceuticals | 1.67 | 1.73M | 23.65 | |
| Mirum Pharmaceuticals Inc | 1.41 | 3.45M | NEW | 10.06 |
| Kempharm Inc note 5.500% 2/0 | 1.32 | 62.42M | -4% | 0.52 |
| Argenx Se | 1.31 | 281000 | 113.96 | |
| Silk Road Medical Inc Common | 1.30 | 979480 | +96% | 32.53 |
| Vericel | 1.28 | 2.08M | 15.14 | |
| Centene Corporation (CNC) | 1.27 | 720400 | +137% | 43.26 |
| Coherus Biosciences | 1.27 | 1.54M | -8% | 20.26 |
| Fate Therapeutics | 1.24 | 1.95M | +14% | 15.53 |
| Alector Inc | 1.22 | 2.08M | +18% | 14.42 |
| Sarepta Therapeutics | 1.17 | 382000 | +23% | 75.32 |
| Select Medical Holdings Corporation (SEM) | 1.16 | 1.71M | -16% | 16.57 |
| Blueprint Medicines | 1.13 | 377200 | -3% | 73.47 |
| Dbv Technologies S A | 1.12 | 3.20M | 8.60 | |
| Sientra | 1.09 | 4.14M | -11% | 6.48 |
| Tandem Diabetes Care Inc | 1.09 | 454334 | +197% | 58.98 |
| Editas Medicine | 1.07 | 1.16M | 22.74 | |
| Ptc Therapeutics Inc conv bd us | 1.06 | 24.88M | 1.04 | |
| Dfb Healthcare Acquistion Co unit 01/30/2023 | 1.05 | 2.50M | 10.32 | |
| Axogen | 0.94 | 1.84M | +106% | 12.48 |
| Xeris Pharmaceuticals Inc | 0.93 | 2.31M | -2% | 9.83 |
| Springworks Therapeutics Inc | 0.93 | 1.05M | NEW | 21.68 |
| Molina Healthcare (MOH) | 0.88 | 197056 | +31% | 109.72 |
| Rocket Pharmaceuticals Inc | 0.84 | 1.77M | +55% | 11.65 |
| Addus Homecare Corp | 0.82 | 252915 | 79.28 | |
| Deciphera Pharmaceuticals Inc | 0.82 | 594725 | -2% | 33.94 |
| Arvinas Ord | 0.81 | 921234 | 21.55 | |
| Mirati Therapeutics | 0.74 | 233000 | -11% | 77.91 |
| Humana (HUM) | 0.70 | 67000 | 255.67 | |
| Wave Life Sciences Ltd shs | 0.68 | 807727 | +20% | 20.53 |
| Ptc Therapeutics I | 0.65 | 471000 | 33.82 | |
| Ardelyx | 0.65 | 3.40M | 4.70 | |
| Wright Medical Group Nv 2.25 20211115 | 0.65 | 13.62M | 1.17 | |
| Reata Pharmaceuticals Inc Cl A stock | 0.64 | 197000 | 80.29 | |
| Galapagos Nv-spon | 0.63 | 101010 | 152.66 | |
| Anaptysbio Inc Common | 0.61 | 425443 | -21% | 34.99 |
| Diplomat Pharmacy | 0.60 | 3.00M | -57% | 4.90 |
| Turning Point Therapeutics I | 0.59 | 387545 | +34% | 37.60 |
| Audentes Therapeutics Inc Com stock | 0.57 | 493901 | 28.09 | |
| Syros Pharmaceuticals | 0.54 | 1.27M | 10.38 | |
| Global Blood Therapeutics In | 0.53 | 268100 | +14% | 48.52 |
| Flamel Technologies Sa | 0.46 | 2.72M | 4.16 | |
| Kiniksa Pharmaceuticals Ltd | 0.44 | 1.27M | -2% | 8.51 |
| Kalvista Pharmaceuticals | 0.42 | 890668 | -26% | 11.60 |
| Mallinckrodt Pub | 0.41 | 4.19M | 2.41 | |
| Inogen | 0.37 | 191660 | NEW | 47.91 |
| Guardant Health Inc | 0.33 | 126000 | NEW | 63.83 |
| BioCryst Pharmaceuticals (BCRX) | 0.32 | 2.77M | -55% | 2.86 |
| eHealth (EHTH) | 0.30 | 110000 | -64% | 66.79 |
| AtriCure (ATRC) | 0.30 | 292777 | NEW | 24.94 |
| Aimmune Therapeutics | 0.29 | 339480 | NEW | 20.94 |
| Avrobio Ord | 0.29 | 500000 | NEW | 14.12 |
| X4 Pharmaceuticals Inc | 0.29 | 563741 | 12.71 | |
| Bridgebio Pharma Inc | 0.25 | 290000 | 21.47 | |
| Teligent Inc New bond | 0.23 | 9.57M | 0.58 | |
| ABIOMED (ABMD) | 0.20 | 27600 | NEW | 177.90 |
| Medicines Company (MDCO) | 0.20 | 100000 | 50.00 | |
| Forty Seven Inc | 0.20 | 750000 | NEW | 6.42 |
| Provention Bio Inc | 0.20 | 725000 | NEW | 6.82 |
| Igm Biosciences Inc Com | 0.18 | 250000 | NEW | 17.75 |
| Alimera Sciences (ALIM) | 0.16 | 7.06M | +16% | 0.57 |
| Aeglea Biotherapeutics | 0.16 | 500046 | 7.69 | |
| Ideaya Biosciences Inc | 0.16 | 422974 | 9.00 | |
| Harpoon Therapeutics Inc | 0.15 | 264497 | -7% | 13.66 |
| BioDelivery Sciences International (BDSI) | 0.14 | 816096 | 4.21 | |
| Morphosys Ag Adr | 0.14 | 124701 | -79% | 27.47 |
| Neuronetics Inc | 0.12 | 339512 | +113% | 8.31 |
| Alphatec Holdings | 0.11 | 536517 | NEW | 5.02 |
| Itamar Med Ltd sponsored ads | 0.11 | 314136 | 8.75 | |
| Synlogic, Inc. | 0.10 | 1.11M | 2.29 | |
| Agile Therapeutics | 0.08 | 1.59M | NEW | 1.18 |
| Alpine Immune Sciences | 0.07 | 406926 | -2% | 3.96 |
| Castle Biosciences Inc | 0.07 | 92477 | NEW | 18.09 |
| Viewray | 0.04 | 378623 | NEW | 2.90 |
| Eyenovia Inc equity | 0.03 | 197069 | -34% | 3.70 |
| Kempharm | 0.02 | 692104 | NEW | 0.69 |
| Neos Therapeutics | 0.02 | 320993 | 1.48 | |
| Menlo Therapeutics Inc | 0.02 | 99622 | -49% | 4.48 |
| Proteon Therapeutics | 0.01 | 1.22M | 0.26 | |
| Constellation Pharmceticls I | 0.01 | 23600 | -87% | 6.44 |
Download CSV 
Past 13F-HR SEC Filings by Deerfield Management Company
- Deerfield Management Company 2019 Q2 filed Aug. 14, 2019
- Deerfield Management Company 2019 Q1 filed May 15, 2019
- Deerfield Management Company 2018 Q4 filed Feb. 14, 2019
- Deerfield Management Company 2018 Q3 filed Nov. 14, 2018
- Deerfield Management Company 2018 Q2 filed Aug. 14, 2018
- Deerfield Management Company 2018 Q1 filed May 15, 2018
- Deerfield Management Company 2017 Q4 filed Feb. 14, 2018
- Deerfield Management 2017 Q3 filed Nov. 13, 2017
- Deerfield Management 2017 Q2 filed Aug. 14, 2017
- Deerfield Management 2017 Q1 filed May 15, 2017
- Deerfield Management 2016 Q4 filed Feb. 14, 2017
- Deerfield Management 2016 Q3 filed Nov. 14, 2016
- Deerfield Management 2016 Q2 filed Aug. 15, 2016
- Deerfield Management 2016 Q1 filed May 16, 2016
- Deerfield Management 2015 Q4 filed Feb. 16, 2016
- Deerfield Management 2015 Q3 filed Nov. 16, 2015
- Deerfield Management 2015 Q1 filed May 15, 2015
- Deerfield Management 2014 Q4 filed Feb. 17, 2015
- Deerfield Management 2014 Q3 filed Nov. 14, 2014